In:
Prenatal Diagnosis, Wiley
Abstract:
What is already known about this topic? Prenatal exome sequencing (ES) can identify a diagnosis in up to one third of pregnancies with fetal structural anomalies and a non‐diagnostic chromosomal microarray. There are disparities in access to genomic technologies, including prenatal diagnostic testing. What does this study add? We report on the perspectives of clinicians from academic centers and community clinics on the utility of and access to prenatal ES. A goal of prenatal ES is to guide clinical care, rather than solely for decision‐making regarding abortion. In academic centers, access to ES is primarily through studies; cost, lack of insurance coverage, and knowledge of genomic sequencing among non‐genetics providers are major barriers to access.
Type of Medium:
Online Resource
ISSN:
0197-3851
,
1097-0223
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
1491217-X